Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_assertion description "[G-CSF has also been applied in priming strategies designed to enhance the sensitivity of leukemia stem cells to cytotoxic agents, in protocols aimed to induce their differentiation and accompanying growth arrest and cell death, and in severe aplastic anemia and myelodysplastic syndrome (MDS) to alleviate anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_assertion evidence source_evidence_literature NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_assertion SIO_000772 20237318 NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_assertion wasDerivedFrom befree-20140225 NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_assertion wasGeneratedBy ECO_0000203 NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP824066.RA3WmPmgEBbPheAyiihYI5zf0jewqU8EzYiaOJt6rA_iQ130_provenance.